From Seekingalpha · Renaissance Capital IPO Research · · 40s
U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline
City Therapeutics and Iambic headline priced at $1.0 billion market cap.
In brief
City Therapeutics and Iambic headline priced at $1.0 billion market cap. City Therapeutics priced its upsized IPO at $1.0 billion market cap to raise $200 million. Originally reported by Seekingalpha.
IPO Activity
Three IPOs and two SPACs priced this week, and two SPACs submitted filings.
City Therapeutics Pricing
City Therapeutics priced its upsized IPO at the midpoint to raise $200 million at a $1.0 billion market cap.
Upcoming Events
No IPOs are currently scheduled for the week ahead as the year’s next mega IPO potentially comes into view.
The big picture
City Therapeutics priced its upsized IPO at $1.0 billion market cap to raise $200 million.
